Better Health,
Brighter Future
Newsroom
Careers
Investors
Patients
HCPs
Worldwide
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Company Information
Company Facts
History
Worldwide Offices
Executive Leadership
Positions & Guidelines
Corporate Philosophy
Our People
Corporate Governance
Risk & Crisis Management
Compliance
From the CEO
Contact Us
We have global presence in more than 70 countries.
LEARN MORE
What We Do
Our Business
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.
Learn more
Research & Development
Our Pipeline
Takeda Clinical Trial Transparency
Publications of Takeda Research Laboratories
Investigator Initiated Sponsored Research
Therapeutic Areas
Our Products
Alliances & Partnerships
Access to Medicines
Suppliers
Sustainable Procurement
Supplier Code of Conduct
Supplier Diversity
Pharmaceutical Supply Chain Initiative
Supplier Qualification & Due Diligence
We focus on our core therapeutic areas.
LEARN MORE
Our Stories
Our Stories
Find out Takeda's stories related on Innovation, Caring and Heritage
Learn more
Innovation
Quality at Takeda
The Key Elements at the Heart of Our Innovation
Caring
Medicine for the World
Safeguarding Plant Diversity
Takeda at TICAD
Going Beyond Medicines
Change the World
An Empowered Women-led Workforce
Heritage
Keys to Aging Gracefully
Corporate Responsibility
Takeda's CSR
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
LEARN MORE
Basic Policies on CSR
Human Rights
Labour
Environment
Anti-Corruption
Corporate Citizenship Activities
Global CSR Program
Takeda Initiative
IDEEL Program
HERhealth
Global Relay for Life
Digital Birth Program
Corporate Citizenship Videos
CSR Data Book
CSR Data Book Survey
Takeda is working to resolve global healthcare issues with people around the world.
LEARN MORE
HOME
Newsroom
News Releases
Share:
Newsroom
News Releases
In the News
Featured Topics
Corporate Materials
Social Media
News Releases
Enter
All
Last 12 months
2017
2016
2015
2014
2013
2012
August 2017
August 22, 2017
Aug 22, 2017
Takeda Submits a New Drug Application for Vedolizumab for the Treatment of Moderately to Severely Ulcerative Colitis in Japan
August 04, 2017
Aug 04, 2017
Takeda and Molecular Templates Announce Multi-Target Research and Licensing Collaboration to Develop Next-Generation Oncology Therapies
August 03, 2017
Aug 03, 2017
Takeda and Cardurion Pharmaceuticals Launch Cardiovascular Development Partnership
August 02, 2017
Aug 02, 2017
Takeda and Marvel Custom Solutions Debut the Full IBD Unmasked Graphic Novel Featuring a Team of Inflammatory Bowel Disease (IBD) Super Heroes
July 2017
July 31, 2017
Jul 31, 2017
SEEDSUPPLY to Launch at Takeda’s Shonan Research Center
July 27, 2017
Jul 27, 2017
Takeda reports 1st Quarter FY2017 results
July 27, 2017
Jul 27, 2017
TESARO and Takeda Enter into Exclusive Licensing Agreement to Develop and Commercialize Novel Cancer Therapy Niraparib in Japan
July 27, 2017
Jul 27, 2017
Takeda selected by major index and sustainability rating institutions concerning Corporate Social Responsibility (CSR)
1
2
3
4
5
TOP
We use cookies to gather web statistics that help us improve our site. We store no personal details.
Accept
Read more
